A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years

por Ivy, Dunbar, Beghetti, Maurice, Juaneda-Simian, Ernesto, Miller, Diane, Lukas, Mary Ann, Ioannou, Chris, Okour, Malek, Narita, Jun, Berger, Rolf M.F.
Publicado 2020